Showing results (231-240 of 266) with videos related to
Sort By:
Pageof 27
Frontiers in Immunology|July 25, 2022
Effect of Dysglycemia on Urinary Lipid Mediator Profiles in Persons With Pulmonary TuberculosisMaría B Arriaga, Farina Karim, Artur T L Queiroz, et al.The Journal of Experimental Medicine|September 7, 2022
GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infectionEduardo P Amaral, Taylor W Foreman, Sivaranjani Namasivayam, et al.Cell Reports|June 1, 2022
CD4 T cells are rapidly depleted from tuberculosis granulomas following acute SIV co-infectionTaylor W Foreman, Christine E Nelson, Keith D Kauffman, et al.Plos One|June 27, 2020
Safety and efficacy of N-acetylcysteine in hospitalized patients with HIV-associated tuberculosis: An open-label, randomized, phase II trial (RIPENACTB Study)Izabella Picinin Safe, Marcus Vinícius Guimarães Lacerda, Vitoria Silva Printes, et al.Memorias Do Instituto Oswaldo Cruz|July 15, 2026
Determinants of HIV-1 virologic suppression in HIV-associated tuberculosis in BrazilFelipe Ridolfi, Gustavo Amorim, David W Haas, et al.The European Respiratory Journal|October 29, 2021
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation studyAkshay N Gupte, Pavan Kumar, Mariana Araújo-Pereira, et al.The Journal of Pathology|September 5, 2014
Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferationAndré Kübler, Brian Luna, Christer Larsson, et al.Frontiers in Immunology|June 27, 2022
Immunologic Biomarkers in Peripheral Blood of Persons With Tuberculosis and Advanced HIVArtur T L Queiroz, Mariana Araújo-Pereira, Beatriz Barreto-Duarte, et al.Science Immunology|January 16, 2021
PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaquesKeith D Kauffman, Shunsuke Sakai, Nickiana E Lora, et al.Frontiers in Immunology|November 28, 2024
Longitudinal mitochondrial bioenergetic signatures of blood monocytes and lymphocytes improve during treatment of drug-susceptible pulmonary tuberculosis patients Monocyte/lymphocyte bioenergetic signatures post-TB treatmentBridgette M Cumming, Kelvin W Addicott, Fernanda Maruri, et al.Pageof 27